- US12618065utility2026Mirna Detargeting System for Tissue Specific Interference0 cites
- US12606846utility2026Materials and Methods for the Treatment of Disorders Associated with the IRF2BPL Gene0 cites
- US12564596utility2026Agents and Methods for Modulating Pathogen Activity0 cites
- US12545909utility2026DUX4 RNA Silencing Using RNA Targeting Crispr-cas13b0 cites
- US12491265utility2025Adeno-associated Virus Vector Delivery of Muscle Specific Micro-dystrophin to Treat Muscular Dystrophy0 cites
- US12480097utility2025Syncytial Oncolytic Herpes Simplex Mutants as Potent Cancer Therapeutics0 cites
- US12472239utility2025Guide RNA for Repairing a Mutant Human Titin Gene Using CRISPR Technology0 cites
- US12453747utility2025Prebiotic Formulations for Prevention of Sepsis and Necroenterocolitis Induced Neurodevelopmental Deficiencies0 cites
- US12419944utility2025DNABII Vaccines and Antibodies with Enhanced Activity0 cites
- US12391928utility2025Recombinant Adeno-associated Virus Products and Methods for Treating Limb Girdle Muscular Dystrophy 2A0 cites
- US12385062utility2025Increasing Tissue Specific Gene Delivery by Capsid Modification0 cites
- US12377170utility2025Adeno-associated Virus Vector Delivery of Β-sarcoglycan and the Treatment of Muscular Dystrophy0 cites
- US12365710utility2025HMGB1 Protein Derivatives for the Removal of Biofilms0 cites
- US12338449utility2025Enhanced Modified Viral Capsid Proteins0 cites
- US12325856utility2025Recombinant Virus Products and Methods for Inhibition of Expression of Myotilin0 cites
- US12285497utility2025Self-complementary Adeno-associated Virus Vector and Its Use in Treatment of Muscular Dystrophy0 cites
- US12263230utility2025Gene Therapy for Limb-girdle Muscular Dystrophy Type 2C0 cites
- US12258573utility2025Adeno-associated Virus Vector Delivery of Alpha-sarcoglycan and the Treatment of Muscular Dystrophy0 cites
Page 1 of 3Next →